EcoDrugPlus

Rho Associated Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSOCUG00000004848
Gene Symbol: ROCK1
2 Cross references
215 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 2

Ensembl ID : ENSOCUG00000017477
Gene Symbol: ROCK2
2 Cross references
304 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSOCUG00000009585
Gene Symbol: SRC
2 Cross references
262 Possible Orthologues:

Tek Receptor Tyrosine Kinase

Ensembl ID : ENSOCUG00000017666
Gene Symbol: TEK
3 Cross references
164 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSOCUG00000007124
Gene Symbol: TTK
2 Cross references
203 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSOCUG00000014366
Gene Symbol: UGCG
2 Cross references
211 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSOCUG00000013074
Gene Symbol: WEE1
2 Cross references
226 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSOCUG00000005874
Gene Symbol: YES1
2 Cross references
259 Possible Orthologues:

Activin A Receptor Like Type 1

Ensembl ID : ENSOCUG00000022530
Gene Symbol: ACVRL1
2 Cross references
353 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSOCUG00000008714
Gene Symbol: ADORA2A
3 Cross references
260 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSOCUG00000010449
Gene Symbol: ADORA2B
2 Cross references
200 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSOCUG00000023239
Gene Symbol: ADORA3
3 Cross references
89 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).